Thyroid cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. DTC patients aged 18-85 years with a clear clinical diagnosis; 2. Clinical data can be obtained for a complete evaluation of the efficacy; 3. Patients with a complete plan of clinical treatment can follow up the patient's progression-free survival (PFS); 4. Volunteer and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Severe liver and kidney damage 2. Pathology or long-term follow-up results may not be available; 3. Unable to obtain relevant control image data and clinical data; 4. Combined with other malignant tumors; 5. Beyond the age range or severely difficult to cooperate; 6. Failure to follow up on PFS; 7. Withdrawal of informed consent; 8. Missed follow-up; 9. Violates the research plan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FNA-Tg; | — |
Countries
China
Contacts
the First Affiliated Hospital of Xi'an Jiaotong University School of Medicine